Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Get a concise action plan for financial emergencies, including prioritizing essentials, securing funds, and communicating with creditors promptly.
16,835 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Meta Platforms signs a multiyear pact with AMD for up to 6 GW of customized GPUs, bolstering a multi-vendor AI chip s...
Astronics faces a pivotal year as 2025 earnings unfold. This guide breaks down the drivers, risks, and actionable ste...
Kalshi announces its first public actions against accounts suspected of trading on confidential information connected...
Jimmy Wales’ Bitcoin bubble call collides with rising on-chain activity and bullish Polymarket bets. Traders see dive...
The latest Freddie Mac survey shows the 30-year fixed rate dipping under 6% for the first time in years, signaling po...
MercadoLibre's 2025 earnings reveal how a Latin American e-commerce and fintech leader is balancing growth with profi...
Prediction markets for Bitcoin show a cautious view, but there may be a stronger upside catalyst many are overlooking...
Investors are watching whispers about Kevin Warsh potentially becoming Fed Chair. This article explains what that cou...
Federal prosecutors dismantle a sprawling fraud machine that used mass texting, scripted pitches, and fake crypto pla...
As regulators tighten age-verification rules and privacy protections, social media companies fighting to curb underag...
Wondering if you should netflix stock right now? This guide breaks down valuation, growth options, and practical step...